ABT

2025Q4BMO

Abbott Laboratories primary · HEALTHCARE · MEDICAL DEVICES

Report 2026-01-22 · Fiscal end 2025-12-31 · Features as of 2026-01-21

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.49
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.4%
IV front—
P/C full—
P/C front—
Features as of2026-01-21

Run-up

Close—
Ret 5d-2.9%
Ret 10d-5.5%
Ret 20d-3.8%
Ret 30d-3.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
1.50Beat
Estimated EPS1.49
Actual revenue
11.5B
Surprise %+0.7%
Beat / missBeat
Beat streak 41
Beat streak 81

Reaction

1-day stock reaction+1.0%
Implied vs actual

Implied 1.4%Actual 10.9%

Gap reaction-10.9%
Day result-10.0%
Next-day upYes
Realized / IV8.07×

Post tape

Post 5d-2.3%
Post 10d+0.4%
Post volume37.1M
Vol ×10d4.92×
Vol ×20d5.96×
Post range7.6%